Trade SCYX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
SCYNEXIS, Inc. (SCYX) is trading at US$4.08, down 3.32% today as of Oct 9, 16:00 EDT. The company has a market capitalisation of US$50.74M. Over the past 52 weeks, SCYX has traded between US$3.53 and US$9.12. On Syfe you can trade SCYX with $0 commission and add it to your watchlist.
| Previous close | US$4.22 |
|---|---|
| Market cap | US$50.74M |
| 52-week range | US$3.53 – US$9.12 |
| Volume | 119.35K |
| Exchange | US |
SCYNEXIS, Inc.
SCYNEXIS, Inc. is a biotechnology company, which engages in the development of novel oral and intravenous triterpenoid antifungal for the treatment of several fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections. The company was founded by Scot Kevin Huber, Terry Eugene Marquardt, Pierre Bernard Jacques Monnet, Russell J. Outcalt, and Yves Joseph Ribeill on November 4, 1999 and is headquartered in Jersey City, NJ.
Year: 2014
SCYNEXIS Names Sanjay Subramanian as CFO
Sep 10, 12:57 PM · MT Newswires
Scynexis Initiates Phase 1 Study of SCY-770 to Treat Autosomal Dominant Polycystic Kidney Disease
Jun 30, 1:28 PM · MT Newswires
SCYNEXIS, Inc. (SCYX) stock is trading at US$4.08, -3.32% from the previous close of US$4.22.
The market cap for SCYNEXIS, Inc. (SCYX) stock is approximately US$50.74M.
The 52-week high for SCYNEXIS, Inc. (SCYX) stock is US$9.12.
The 52-week low for SCYNEXIS, Inc. (SCYX) stock is US$3.53.
SCYNEXIS, Inc. (SCYX) does not currently pay a dividend.
Stay on top of SCYX
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
